Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.
Briers Y, Walmagh M, Van Puyenbroeck V, Cornelissen A, Cenens W, Aertsen A, Oliveira H, Azeredo J, Verween G, Pirnay JP, Miller S, Volckaert G, Lavigne R.
Briers Y, et al. Among authors: aertsen a.
mBio. 2014 Jul 1;5(4):e01379-14. doi: 10.1128/mBio.01379-14.
mBio. 2014.
PMID: 24987094
Free PMC article.